Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Antonia Marazioti (Rio, Patras, Greece), Antonia Marazioti, Malamati Vreka, Anastasios Giannou, Theodora Agalioti, Nikolaos Kanellakis, Magdalini Spella, Ioanna Giopanou, Georgios Stathopoulos. LATE-BREAKING ABSTRACT: Host-environmental IL-1ß drives mutant KRAS-IKKa addiction in malignant pleural effusion. Eur Respir J 2015; 46: Suppl. 59, 5001

Member's Comments

No comment yet.

Related content which might interest you: A requirement for kras signaling in malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 A conditional contribution of mast cells to malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 A myeloid NF-κbeta response in malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 LATE-BREAKING ABSTRACT: A proteomic study of benign and malignant pleural effusions Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Solitary fibrous tumour of the pleural: Two malignant cases Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 LATE-BREAKING ABSTRACT: Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Activated KRAS signaling triggers malignant pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Role of tumor derived versican in experimental malignant pleural mesothelioma Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016 Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Efficacy of cytology, cell blocks and thoracoscopic pleural biopsy in malignant pleural effusion diagnosis Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE) Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Lent score validation on patients with malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Malignant pleural mesothelioma: Current status and future projections in Turkey Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 A novel pleural-bladder pump for management of pleural effusion Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Malignant pleural effusion as the initial manifestation of gynecological malignancies Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Yield of pleural cytology and macroscopic pleural invasion in metastatic pleural effusion Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014